Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists)

NCT04300881 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Enrollment

Conditions

Vitreomacular Traction
Subretinal Edema

Interventions

DRUG: Eplerenone

Sponsor

Wagner Macula & Retina Center

Collaborators

[object Object]